Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 3
2020 2
2021 3
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

8 results
Results by year
Filters applied: . Clear all
Page 1
PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells.
Mangiapane LR, Nicotra A, Turdo A, Gaggianesi M, Bianca P, Di Franco S, Sardina DS, Veschi V, Signore M, Beyes S, Fagnocchi L, Fiori ME, Bongiorno MR, Lo Iacono M, Pillitteri I, Ganduscio G, Gulotta G, Medema JP, Zippo A, Todaro M, De Maria R, Stassi G. Mangiapane LR, et al. Among authors: ganduscio g. Gut. 2022 Jan;71(1):119-128. doi: 10.1136/gutjnl-2020-323553. Epub 2021 Jan 12. Gut. 2022. PMID: 33436496 Free PMC article.
18F-Facbc in Prostate Cancer: A Systematic Review and Meta-Analysis.
Laudicella R, Albano D, Alongi P, Argiroffi G, Bauckneht M, Baldari S, Bertagna F, Boero M, Vincentis G, Sole AD, Rubini G, Fantechi L, Frantellizzi V, Ganduscio G, Guglielmo P, Nappi AG, Evangelista L; on the behalf of Young AIMN Working Group. Laudicella R, et al. Among authors: ganduscio g. Cancers (Basel). 2019 Sep 11;11(9):1348. doi: 10.3390/cancers11091348. Cancers (Basel). 2019. PMID: 31514479 Free PMC article. Review.
CHK1 inhibitor sensitizes resistant colorectal cancer stem cells to nortopsentin.
Di Franco S, Parrino B, Gaggianesi M, Pantina VD, Bianca P, Nicotra A, Mangiapane LR, Lo Iacono M, Ganduscio G, Veschi V, Brancato OR, Glaviano A, Turdo A, Pillitteri I, Colarossi L, Cascioferro S, Carbone D, Pecoraro C, Fiori ME, De Maria R, Todaro M, Screpanti I, Cirrincione G, Diana P, Stassi G. Di Franco S, et al. Among authors: ganduscio g. iScience. 2021 May 29;24(6):102664. doi: 10.1016/j.isci.2021.102664. eCollection 2021 Jun 25. iScience. 2021. PMID: 34169240 Free PMC article.
Nobiletin and Xanthohumol Sensitize Colorectal Cancer Stem Cells to Standard Chemotherapy.
Turdo A, Glaviano A, Pepe G, Calapà F, Raimondo S, Fiori ME, Carbone D, Basilicata MG, Di Sarno V, Ostacolo C, Parrino B, Cascioferro S, Pecoraro C, Di Franco S, Bellavia D, Gaggianesi M, Veschi V, Lo Iacono M, Ganduscio G, Pantina VD, Mangiapane LR, Bongiorno MR, Alessandro R, Todaro M, De Maria R, Diana P, Campiglia P, Stassi G. Turdo A, et al. Among authors: ganduscio g. Cancers (Basel). 2021 Aug 4;13(16):3927. doi: 10.3390/cancers13163927. Cancers (Basel). 2021. PMID: 34439086 Free PMC article.
Choline PET/CT features to predict survival outcome in high risk prostate cancer restaging: a preliminary machine-learning radiomics study.
Alongi P, Laudicella R, Stefano A, Caobelli F, Comelli A, Vento A, Sardina D, Ganduscio G, Toia P, Ceci F, Mapelli P, Picchio M, Midiri M, Baldari S, Lagalla R, Russo G. Alongi P, et al. Among authors: ganduscio g. Q J Nucl Med Mol Imaging. 2020 Jun 15. doi: 10.23736/S1824-4785.20.03227-6. Online ahead of print. Q J Nucl Med Mol Imaging. 2020. PMID: 32543166
Potential clinical value of quantitative fluorine-18-fluorodeoxyglucose-PET/computed tomography using a graph-based method analysis in evaluation of incidental lesions of gastrointestinal tract: correlation with endoscopic and histopathological findings.
Alongi P, Laudicella R, Gentile R, Scalisi S, Stefano A, Russo G, Grassedonio E, Albano D, Pompei G, Rossi F, Raimondo D, Ganduscio G, Midiri M, Sinagra E. Alongi P, et al. Among authors: ganduscio g. Nucl Med Commun. 2019 Oct;40(10):1060-1065. doi: 10.1097/MNM.0000000000001062. Nucl Med Commun. 2019. PMID: 31365492